The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. Immunosuppression was found to be associated with chronic inflammatory mediators including cytokines, chemokines and growth factors produced by cancer and stroma cells. Long-term intensive production of these factors induces the formation of myeloid-derived suppressor cells (MDSCs) representing one of the most important players mediating immunosuppression. Moreover, MDSCs could not only inhibit anti-tumor immune reactions but also directly stimulate tumor growth and metastasis. Therefore, understanding the mechanisms of their generation, expansion, recruitment and activation is required for the development of novel strategies for tumor immunotherapy.

• Publication year

  2016

• Venue

  Vaccines

• Publication date

  2016-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/vaccines4040036PMID 27827871PMCID 5192356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cited by this paper
• Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab

  2016cited by this paper
• Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.

  2016cited by this paper
• Clinical significance of circulating CD33+CD11b+HLA-DR- myeloid cells in Stage-IV melanoma patients treated with ipilimumab

  2016cited by this paper
• MDSCs in cancer: Conceiving new prognostic and therapeutic targets.

  2016cited by this paper
• The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

  2016influential reference
• TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide

  2016cited by this paper
• Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma

  2016cited by this paper
• Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

  2016cited by this paper
• Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

  2015cited by this paper
• Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

  2015cited by this paper
• GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential

  2015cited by this paper
• Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

  2015cited by this paper
• CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.

  2015cited by this paper
• Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients

  2015cited by this paper
• Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway

  2015cited by this paper
• Chemokines and immunity

  2015cited by this paper
• Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.

  2015cited by this paper
• Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

  2015cited by this paper
• Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

  2015cited by this paper
• Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate

  2015cited by this paper
• Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma

  2014cited by this paper
• Myeloid‐derived suppressor cell heterogeneity in human cancers

  2014influential reference
• Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

  2014cited by this paper
• Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

  2014cited by this paper
• PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

  2014cited by this paper
• Interactions between innate and adaptive lymphocytes

  2014cited by this paper
• Myeloid‐derived suppressor cells in malignant melanoma

  2014cited by this paper
• Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

  2013cited by this paper
• Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production

  2013cited by this paper
• Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

  2013cited by this paper
• The interleukin-1 family: back to the future.

  2013influential reference
• CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

  2013cited by this paper
• History of myeloid-derived suppressor cells

  2013cited by this paper
• Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients

  2013cited by this paper
• Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins

  2013cited by this paper
• Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells

  2013cited by this paper
• Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model

  2013cited by this paper
• Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.

  2013cited by this paper
• Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.

  2013cited by this paper
• Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

  2013cited by this paper
• The roles of TGFβ in the tumour microenvironment

  2013cited by this paper
• Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma

  2013cited by this paper
• On the armament and appearances of human myeloid-derived suppressor cells.

  2012influential reference
• Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner

  2012cited by this paper
• Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis

  2012cited by this paper
• Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid‐derived suppressor cells during SIV and HIV infection

  2012influential reference
• Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives

  2012cited by this paper
• Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models

  2012cited by this paper
• Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells

  2012cited by this paper
• Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

  2012influential reference
• Coordinated regulation of myeloid cells by tumours

  2012influential reference
• Melanoma-induced immunosuppression and its neutralization.

  2012cited by this paper
• Recent advances on the role of tumor exosomes in immunosuppression and disease progression.

  2012cited by this paper
• Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release

  2012cited by this paper
• New insights into chronic inflammation-induced immunosuppression.

  2012influential reference
• Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.

  2012cited by this paper
• Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice

  2012cited by this paper
• Regulation of Immune Responses by Prostaglandin E2

  2012cited by this paper
• Anti‐IL‐6 receptor mAb eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T‐cell responses

  2012cited by this paper
• Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.

  2012cited by this paper
• Abstract 794: Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression and lung tumorigenesis

  2011cited by this paper
• The Two Faces of Interferon-γ in Cancer

  2011cited by this paper
• A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

  2011cited by this paper
• PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

  2011cited by this paper
• Transcription factors in myeloid-derived suppressor cell recruitment and function.

  2011cited by this paper
• COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

  2011cited by this paper
• Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

  2011cited by this paper
• Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

  2011cited by this paper
• IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

  2011cited by this paper
• Targeting immune suppressing myeloid-derived suppressor cells in oncology.

  2011cited by this paper
• Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

  2011cited by this paper
• Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment

  2011cited by this paper
• Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma.

  2011cited by this paper
• Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

  2011cited by this paper
• S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

  2011cited by this paper
• Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells

  2010cited by this paper
• Multiple functions of CXCL12 in a syngeneic model of breast cancer

  2010cited by this paper
• Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.

  2010cited by this paper
• GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells

  2010cited by this paper
• HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

  2010cited by this paper
• Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

  2010cited by this paper
• IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and function

  2010cited by this paper
• Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

  2010influential reference
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

  2010cited by this paper
• CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

  2010cited by this paper
• Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells

  2010cited by this paper
• Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

  2010cited by this paper
• Subsets, expansion and activation of myeloid-derived suppressor cells

  2010influential reference
• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• The polarization of immune cells in the tumour environment by TGFβ

  2010cited by this paper
• Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.

  2010cited by this paper
• Distinct populations of metastases‐enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra‐abdominal tumor

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

  2010cited by this paper
• Modulators of arginine metabolism support cancer immunosurveillance

  2009cited by this paper
• Complex and Context Dependent Regulation of Hematopoiesis by TGF‐β Superfamily Signaling

  2009cited by this paper
• The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

  2009cited by this paper
• Therapeutic targeting of myeloid-derived suppressor cells.

  2009cited by this paper

• Immunomodulation of the Prostate Tumor Microenvironment Following Inorganic Arsenic Exposure.

  2026cites this paper
• In vitro generation of human CD14+ MDSC-like cells from normal human monocytes.

  2026cites this paper
• Risk factors for recurrence of vulvar high-grade squamous intra-epithelial lesions: long-term follow-up of the PITVIN Study (primary imiquimod vs surgery for vulvar intra-epithelial neoplasia).

  2026cites this paper
• Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines

  2026cites this paper
• Methylglyoxal: Hijack-to-survive paradigm of cancer progression

  2026cites this paper
• Immune Infiltration Landscape in Osteosarcoma: Clinical Implications for Prognosis and Therapy

  2026cites this paper
• Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy

  2025cites this paper
• GuBenPeiYuan Formula Inhibits Lung Cancer Metastasis by Suppressing Myeloid-Derived Suppressor Cells and Related Immune Cells

  2025cites this paper
• Multi-omics analysis of copper metabolism-related molecular subtypes and risk stratification for osteosarcoma

  2025cites this paper
• Identification of Biomarkers Based on Starvation Response-Related Genes for Assessing the Immune Profile and Prognosis in Lung Adenocarcinoma

  2025cites this paper
• M1 Macrophage‐Derived Extracellular Particles Induce Cell Death in MDA‐MB‐231 Cells

  2025cites this paper
• Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer

  2025cites this paper
• Protocol to detect neutral lipids with BODIPY staining in myeloid-derived suppressor cells in mouse mammary tumors

  2025cites this paper
• Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.

  2025cites this paper
• [A coupled diffusion-based model of interaction between tumor metastasis and myeloid-derived suppressive cells].

  2025cites this paper
• LSI312A Modulates Myeloid-derived Suppressor Cell-Mediated Immunosuppression via NLRP3 Inflammasome Inhibition.

  2025cites this paper
• Constructing a Pan-Cancer Prognostic Model via Machine Learning Based on Immunogenic Cell Death Genes and Identifying NT5E as a Biomarker in Head and Neck Cancer

  2025cites this paper
• Dendritic Cell Immunotherapy for Solid Tumors: Advances in Translational Research and Clinical Application

  2025cites this paper
• Tumor-infiltrating neutrophil is an independent prognostic factor in pancreatic ductal adenocarcinoma

  2025cites this paper
• Lyophilized Listeria monocytogenes vaccines for storage at non-ultra-low temperatures and cancer therapy.

  2025cites this paper
• Chemokines: humble yet mighty players in the tumour microenvironment

  2025cites this paper
• TIGAR regulated by HPV E6 is correlated with disease stage, drug sensitivity, and immune microenvironment in cervical cancer

  2025cites this paper
• Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma.

  2025cites this paper
• Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer

  2025influential citation
• Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles

  2025cites this paper
• Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma

  2025cites this paper
• Elimination of senescent cells with senolytic host-directed therapy reduces tuberculosis progression in mice

  2025cites this paper
• Circular RNAs: key players in tumor immune evasion

  2025cites this paper
• Harnessing myeloid cells in cancer

  2025cites this paper
• Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy.

  2025cites this paper
• Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma

  2025cites this paper
• Age-specific tumor-associated macrophage biomarkers underlie metastasis and immune dysregulation in thyroid cancer

  2025cites this paper
• CXCL12 expression and the survival of patients with gastric cancer: a meta-analysis

  2025cites this paper
• The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors

  2025cites this paper
• Lnk deficiency attenuates the immunosuppressive capacity of MDSCs via ferroptosis to suppress tumor development

  2025cites this paper
• BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy

  2025cites this paper
• Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment

  2025cites this paper
• Targeting the tumor microenvironment in triple-negative breast cancer: Biological insights and therapeutic opportunities.

  2025cites this paper
• The immune microenvironment in tumors: focus on canine and feline spontaneous neoplasms

  2025cites this paper
• Understanding the role of oral and vaginal microbiomes in HPV-related cervical, head, and neck cancers: knowledge gaps and feasibility in Sub-Saharan Africa

  2025cites this paper
• Myeloid-Derived Suppressor Cells Enhance Wound Healing in a Murine Model of Corneal Injury.

  2025cites this paper
• The Influence of the Colorectal Cancer Immune Microenvironment on Resistance to Cetuximab: Mechanisms and Potential Therapeutic Strategies

  2025cites this paper
• The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the Number of Myeloid-Derived Suppressor Cells (MDSCs) via the JAK2/STAT3 Pathway

  2025cites this paper
• Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

  2025cites this paper
• Harnessing the innate immune system for glioblastoma therapeutics.

  2025cites this paper
• Advancing Lymph Node Metastasis in Head and neck squamous cell carcinoma: Integrative Mechanisms, Emerging Diagnostics, and Translational Therapies.

  2025cites this paper
• Adoptive cell therapy for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells following standard post-resection chemotherapy and radiotherapy: current strategy and future directions

  2024cites this paper
• Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications.

  2024cites this paper
• GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process

  2024cites this paper
• Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications

  2024cites this paper
• Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer

  2024cites this paper
• The role of neutrophils in osteosarcoma: insights from laboratory to clinic

  2024cites this paper
• Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues

  2024cites this paper
• Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress

  2024cites this paper
• The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review

  2024cites this paper
• Early life vaccination reprograms the metabolism and function of myeloid cells in neonates

  2024cites this paper
• Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors

  2024cites this paper
• Mechanisms of immunotherapy resistance in small cell lung cancer

  2024cites this paper
• Barriers to T Cell Functionality in the Glioblastoma Microenvironment

  2024cites this paper
• Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma

  2024cites this paper
• MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes.

  2024cites this paper
• Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review

  2024cites this paper
• Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria

  2024cites this paper
• Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy

  2024cites this paper
• Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer

  2024cites this paper
• Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis

  2024cites this paper
• The pharmacogenomic and immune landscape of snoRNAs in human cancers.

  2024cites this paper
• Application of nanotechnology in the treatment of hepatocellular carcinoma

  2024cites this paper
• Crucial role of dendritic cells in the generation of anti-tumor T-cell responses and immunogenic tumor microenvironment to suppress tumor development

  2024cites this paper
• Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review

  2024cites this paper
• Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives.

  2024cites this paper
• Investigating the Immune-Stimulating Potential of β-Glucan from Aureobasidium pullulans in Cancer Immunotherapy

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade

  2024cites this paper
• Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cells

  2024cites this paper
• The role and mechanism of cinnamaldehyde in cancer

  2024cites this paper
• Dual roles of myeloid-derived suppressor cells in various diseases: a review

  2024influential citation
• β-Glucan Subverts the Function of Myeloid Cells in Neonates

  2024cites this paper
• Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix

  2024cites this paper
• The inositol-requiring enzyme 1 (IRE1) endoplasmic reticulum stress pathway promotes MDA-MB-231 cell survival and renewal in response to the aryl-ureido fatty acid CTU.

  2024cites this paper
• Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies

  2024cites this paper
• Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells

  2024cites this paper
• CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy

  2024cites this paper
• Myeloid-Derived Suppressor Cells Promote Allograft Survival By Suppressing Treg Dysfunction in High-Risk Corneal Transplantation.

  2024cites this paper
• Fine tuning of the innate and adaptive immune responses by Interleukin-2

  2024cites this paper
• RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors

  2024cites this paper
• Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect.

  2024cites this paper
• Progress in mechanism-based diagnosis and treatment of tuberculosis comorbid with tumor

  2024cites this paper
• Characterization of myeloid‐derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia

  2024cites this paper
• Advances on immunotherapy for osteosarcoma

  2024cites this paper
• Measurement of Metabolic Alteration in Immune Cells Under Hypoxia.

  2024cites this paper
• Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3

  2024cites this paper
• Reactivation of Anticancer Immunity by Resetting Interorgan Crosstalk in Immune-Suppressive Cells with a Nanoparticulated Anti-Inflammatory Drug.

  2023cites this paper
• Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease

  2023cites this paper
• Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy

  2023cites this paper
• Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients

  2023cites this paper
• In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1.

  2023cites this paper
• Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma

  2023cites this paper
• NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomas

  2023cites this paper
• Inflammation-Associated Cytotoxic Agents in Tumorigenesis

  2023cites this paper